Skip to main content
. 2024 May 7;16(5):623. doi: 10.3390/pharmaceutics16050623

Table 1.

Detailed single-crystal X-ray diffraction data of polymorphs.

Identification Code GW-1 GW-2 GW-3 GW-4
Empirical formula C21H18F3NO3S2 C21H18F3NO3S2 C21H18F3NO3S2 C21H18F3NO3S2
Formula weight 453.48 453.48 453.48 453.48
Temperature/K 293(2) 293(2) 293(2) 293(2)
Crystal system monoclinic monoclinic monoclinic orthorhombic
Space group P21/c P21/n C2/c Pca21
a/Å 4.75852(13) 10.92669(10) 33.1318(18) 35.1542(3)
b/Å 19.4117(6) 9.68349(11) 4.5002(2) 4.906
c/Å 22.6359(6) 19.7719(2) 29.4838(11) 24.1208(3)
α/° 90 90 90 90
β/° 94.909(3) 98.2167(10) 107.691(5) 90
γ/° 90 90 90 90
Volume/Å3 2083.23(11) 2070.56(4) 4188.1(4) 4159.78(6)
Z 4 4 8 8
Z’ 1 1 1 2
ρcalc g/cm3 1.446 1.455 1.438 1.447
μ/mm−1 2.769 2.785 2.754 2.773
F(000) 936.0 936.0 1872.0 1872.0
Crystal size/mm3 0.2 × 0.1 × 0.1 0.25 × 0.2 × 0.15 0.3 × 0.05 × 0.04 0.25 × 0.15 × 0.10
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54184)
2Θ range/° 6.008 to 141.96 8.758 to 141.298 6.294 to 149.676 6.222 to 141.31
Index ranges −5 ≤ h ≤ 5, −23 ≤ k ≤ 22, −27 ≤ l ≤ 27 −13 ≤ h ≤ 13, −11 ≤ k ≤ 11, −22 ≤ l ≤ 24 −38 ≤ h ≤ 40, −5 ≤ k ≤ 5, −36 ≤ l ≤ 26 −42 ≤ h ≤ 42, −5 ≤ k ≤ 5, −27 ≤ l ≤ 29
Reflections collected 12,876 29,259 7093 59,180
Independent reflections 3951 [Rint = 0.0281, Rsigma = 0.0261] 3936 [Rint = 0.0247, Rsigma = 0.0130] 3938 [Rint = 0.0224, Rsigma = 0.0365] 7692 [Rint = 0.0498, Rsigma = 0.0239]
Data/restraints/parameters 3951/0/277 3936/1/274 3938/1/277 7692/3/553
Goodness-of-fit on F2 1.067 1.071 1.188 1.035
Final R indexes [I ≥ 2σ (I)] R1 = 0.0481, wR2 = 0.1241 R1 = 0.0556, wR2 = 0. 1968 R1 = 0.0538, wR2 = 0.1620 R1 = 0.0514, wR2 = 0.1377
Final R indexes [all data] R1 = 0.0641, wR2 = 0.1360 R1 = 0.0625, wR2 = 0.2041 R1 = 0.0845, wR2 = 0.1892 R1 = 0.0553, wR2 = 0.1435
Largest diff. peak/hole/e Å−3 0.35/−0.24 1.04/−0.59 0.54/−0.34 0.98/−0.25
Flack parameter 0.54(2)